Discussion Gadopentetate dimeglumine increasingly is being used as an IV contrast agent
in MR imaging. In clinical trials with 3700 patients to date, common adverse reactions have …

A double-blind, randomized parallel phase III study in MR imaging of the central nervous
system was conducted to compare the safety and diagnostic utility of gadodiamide injection …

The tolerance and diagnostic efficacy of a new nonionic, intravenous MRI contrast medium,
gadodiamide injection (Omniscan®) are reported and compared with those of gadolinium …

To investigate the safety, patient tolerance, and efficacy with 0.3 mmol/kg gadopentetate
dimeglumine in magnetic resonance (MR) imaging of the central nervous system (CNS), a …

Discussion As the diagnostic value of contrast-enhanced MR imaging has become evident
(3], gadolinium is being used with increased frequency in radiologic practices. Although no …

This study compared the safety and tolerability of gadodiamide injection at the standard
dose (0.1 mmol/kg) and at a higher dose (0.3 mmol/kg) in 289 patients participating in a …

A multicenter double-blind randomized study was designed to evaluate and compare the
safety and diagnostic efficacy of gadopentetate dimeglumine (Gd-DTPA)(0.1 mmol/kg) …

Gadopentetate dimeglumine is an intravenous contrast medium used in magnetic
resonance imaging. To determine its safety, the authors summarized data concerning …

PURPOSE To evaluate the clinical utility and safety of gadopentetate dimeglumine as a
contrast agent for MR of the brain in patients younger than 2 years of age. METHODS In 125 …

Seventy-nine patients with known or suspected central nervous system lesions were studied
with MRI in a phase III double-blind study. Forty were given gadopentetate dimeglumine (Gd …